Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2022-01-03 , DOI: 10.1111/apt.16760
Marie Decraecker ₁ , Dan Dutartre ₂ , Jean-Baptiste Hiriart ₁ , Marie Irles-Depé ₁ , Faiza Chermak ₁ , Juliette Foucher ₁ , Victor de Lédinghen _{1,

3}

Affiliation

Non-invasive assessment of fibrosis is predictive of the prognosis of non-alcoholic and alcoholic fatty liver disease but this has not been demonstrated in metabolic (dysfunction)-associated fatty liver disease (MAFLD).

中文翻译：